LANTERN PHARMA INC's ticker is LTRN and the CUSIP is 51654W101. A total of 26 filers reported holding LANTERN PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,705 | -41.4% | 20,148 | -3.1% | 0.00% | – |
| Q2 2023 | $117,305 | +13.2% | 20,799 | -3.0% | 0.00% | – |
| Q1 2023 | $103,603 | -17.9% | 21,450 | +2.7% | 0.00% | – |
| Q4 2022 | $126,188 | +28.8% | 20,892 | +1.8% | 0.00% | – |
| Q3 2022 | $98,000 | -24.0% | 20,520 | -9.8% | 0.00% | – |
| Q2 2022 | $129,000 | -21.3% | 22,762 | -1.4% | 0.00% | – |
| Q1 2022 | $164,000 | -13.7% | 23,074 | -3.9% | 0.00% | – |
| Q4 2021 | $190,000 | -26.4% | 24,010 | +4.1% | 0.00% | – |
| Q3 2021 | $258,000 | -29.5% | 23,074 | -8.1% | 0.00% | – |
| Q2 2021 | $366,000 | -14.7% | 25,117 | +6.2% | 0.00% | – |
| Q1 2021 | $429,000 | +324.8% | 23,650 | +351.2% | 0.00% | – |
| Q4 2020 | $101,000 | +7.4% | 5,241 | +4.6% | 0.00% | – |
| Q3 2020 | $94,000 | – | 5,009 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SANDERS MORRIS HARRIS LLC | 365,930 | $1,721,000 | 0.42% |
| CM Management, LLC | 50,000 | $239,000 | 0.27% |
| WOLFF WIESE MAGANA LLC | 30,462 | $146,000 | 0.12% |
| Redmond Asset Management, LLC | 49,502 | $237,000 | 0.09% |
| CARLSON CAPITAL L P | 168,000 | $803,000 | 0.06% |
| NewEdge Advisors, LLC | 171,019 | $817,000 | 0.01% |
| Sigma Planning Corp | 17,500 | $84,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 3,984 | $19,000 | 0.00% |
| NORTHERN TRUST CORP | 12,629 | $60,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |